Medtech resource center

The U.S. ENT device market is projected to grow modestly through 2034, driven by rising pharmaceutical use, cost pressures, and a shift toward resorbable nasal packing, with nasal packing and myringotomy/tympanostomy devices leading segment growth.

The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement will drive overall pulse generator unit volume growth in Japan.

The Asia Pacific dental implant market is set for strong growth through 2034, fueled by rising demand, affordability initiatives in China, and demographic shifts—though reimbursement challenges and commoditization may temper its full potential.

The European EP mapping and ablation device market will grow moderately through 2034, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation and diagnostic technologies, increasing adoption of AI to enhance ablation procedures, increased healthcare spending, favorable clinical guidelines supporting cardiac ablation, and clinical evidence supporting the uptake of premium-priced devices.

The Japanese GI endoscopy device market is projected to experience modest expansion driven by favorable treatment and screening guidelines, as well as an aging population that is contributing to cases of GI-related diseases.

The Asia Pacific large-joint reconstructive implant market is experiencing moderate growth driven by an increasing number of elective procedures, a rising elderly population affected by arthritis, and the growing adoption of advanced knee and hip implants equipped with navigation systems.

The ease-of-use, high cost-effectiveness, reduced patient readmission rates, and rising physician awareness of ORC-based hemostats will continue to drive growth in the market.

Driven by innovation but tempered by safety concerns, the US infusion pump market is set for moderate growth through 2034.

Driven by the rising prevalence of gynecological diseases and aging population in this region, the Asia Pacific gynecological device market will continue to witness modest growth through 2034.

The European market for aortic repair devices is expected to expand modestly, driven by the increasing availability of devices that allow endovascular treatment of more complex aneurysms, particularly in the aortic arch and thoracoabdominal aorta.

The US pulmonology device market will grow modestly over the forecast period through 2034.

The Japanese gynecological device market will experience slow but steady growth through 2034.

The Middle Eastern aesthetic injectable market is expected to experience rapid growth through 2034.

The Latin American aesthetic injectable market is expected to experience rapid growth through 2034.

The landscape of the US cardiac rhythm management device market is poised for dynamic change through 2033, with trends varying by device segment.

The rise of GLP-1 receptor agonists is significantly transforming the landscape of obesity treatment, impacting the growth of bariatric procedures and affecting device sales.

Dee Chaudhary, BA MBA, Principal at Commercial Strategy Consulting, Clarivate, recently spoke with First Report Managed Care to share insights from her Asembia 2025 presentation on the strategic design of patient services programs. Drawing on real-world data, third-party perspectives, and patient stories, Dee highlights best practices for creating impactful programs that deliver measurable benefits for both patients and providers.

Despite regional limitations, favorable patient demographics expect to drive moderate growth in the overall orthopedic market in Latin America.

The overall dental BGS market is poised for moderate growth over the forecast period. The market is primarily driven by an increasing aging population, which is increasing the prevalence of dental issues,…

The US sports medicine device market will grow moderately through 2033, driven by improved surgeon training and the adoption of premium-priced products.

The US PV device market is currently seeing a high volume of innovation, with adoption of new, premium technologies and expanding indication approvals for existing devices supporting the market.

The US cardiac assist device market, although encumbered by recurring device recalls, will continue to grow rapidly due to new product development, the availability and expanded use of devices for a wider range of patients, and favorable reimbursement conditions.

The European large-joint reconstructive implant market is poised for long-term growth, driven by the adoption of innovative technologies such as 3-D printed implants and smart implants, as well as robotic- and navigation-assisted surgeries that facilitate better patient outcomes.

The US market for patient monitoring devices will experience modest growth over the forecast period, driven by the home care, neurological and hemodynamic monitoring device markets.

Fueled by product innovation, rising kidney stone prevalence, and an aging population, the US market for urological devices will grow at a moderate rate through 2033, driven particularly by rising revenues for BPH devices—especially Aquablation—single-use endoscopes, and UI devices.

This snapshot from the AAOS 2025 conference highlights key trends about the shift in orthopedic procedures in ASCs.

This snapshot from AAOS 2025 highlights insights into advancements in orthopedic surgical robotics, including innovative systems, open-platform adoption, and future market growth.

The US heart valve device market has seen rapid shifts in market dynamics, from renewed growth in the surgical heart valve device segment to the introduction of novel products and key approvals of existing products for new indications.

The US neurostimulation device market will be driven by continuous product innovation, including product launches and device improvements targeting expanded indications.

The Clarivate Medtech Trends to Watch in 2024 report noted the resilience of the medtech sector in the face of changing macroeconomic factors and the preparation required to navigate the market’s many complexities.

The global aesthetics market is projected to reach €22.9 billion by 2028, growing at a CAGR of 8% from 2019 to 2028. Key trends driving this growth include natural-looking treatments, combined treatments, and the influence of social media.

The US pulmonology device market will grow modestly over the forecast period, driven mainly by the faster procedure growth in many bronchoscopy procedures, such as endobronchial valve placement and bronchial biopsy, as well as the adoption of disposable bronchoscopes and other premium-priced technologies.

The global market for hernia repair devices will grow modestly over the forecast period. View the new Market Snapshot for comprehensive data and analysis on the state of the market in the US, Europe, Asia Pacific, and Latin America from 2019 through 2033.

In this report, Clarivate data and analytics sketch out what drivers and companies are behind the lightning-fast rise of this revolutionary medical technology, along with its impacts on the broader marketplace for atrial fibrillation treatments and what’s next.

Among key medtech cardiovascular market trends, we’re seeing several transcatheter valve replacement technologies expected to chart similar market growth trajectories as transcatheter aortic valve replacement (TAVR), along with projected high double-digit growth in the pulsed field ablation (PFA) market and a specific market to watch. Learn more in our new infographic.

The global laparoscopic surgical robotic device market will grow due to strong demand for robotic-assisted procedures. Factors driving this demand include increasing global penetration, favorable clinical outcomes, and new competitors entering the market, challenging Intuitive Surgical’s dominance. Read the new Market Snapshot to learn more.

Gain insight into what’s trending and what’s next in the global orthopedic surgical device market from our experts.

The growing popularity of middle meningeal artery embolization in treating chronic subdural hematoma is being fueled by promising preliminary results from the EMBOLISE, STEM, and MAGIC-MT trials.

Navigating the complexities of groundbreaking treatments can create headwinds. With innovations like pulsed field ablation (PFA) at the forefront, challenges such as financial uncertainties, regulatory shifts, and global adoption become paramount.

Medtech companies must navigate a raft of external variables to deliver innovation to patients, and the industry is still in a tenuous recovery after a challenging period of unpredictability and uncertainty.

The in vitro diagnostics (IVD) market is experiencing a significant transformation due to an increased demand for IVDs, technological advancements, and the emergence of multiplex disease testing.

The Medical Technologies to Watch report from Clarivate spotlights medical technologies poised to deliver transformative advances in standards of care and realize better patient outcomes.

Since the FDA’s approval of the first pulsed field ablation (PFA) system in the U.S. last December, PFA technology has rapidly reconfigured the electrophysiology market in the U.S. and ramped up sales of PFA systems in Europe.

The medical technology industry is emerging from a turbulent pandemic era strong, with some really exciting innovations making their way to patients, several of which we showcased in our recent Medical Technologies to Watch report.

Are the powerful weight loss and diabetes treatments a lose-lose for medical technology companies? Not necessarily.

Michael Ward caught up with three leaders from the diagnostics industry to examine the challenges the sector faces and opportunities for the companies able to navigate those challenges successfully.

The Clarivate Medical Technologies to Watch: Surgical Robotics webinar spotlights one of the medical technologies poised to deliver transformative advances in standards of care and realize better patient outcomes.